Back to Trades
Total Value
$30.6K
Net $30.6K bought
Filing Date
Apr 1, 2026
1 transaction
Purchases
$30.6K
1 transaction
Trade Summary
On Mar 31, 2026, Teleman Dan Benjamin, Chief Executive Officer, Director, purchased $30.6K of Nasus Pharma Ltd (NSRX) across 1 transaction. The filing covers Ordinary Shares and reflects net buying of $30.6K. Reported prices ranged from $2.04. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Nasus Pharma Ltd
- Ticker Symbol
- NSRX
- CIK
- 0002029039
Insider Information
- Role
- Chief Executive Officer, Director
Filing Details
- Filing Date
- Apr 1, 2026
- Transaction Date
- Mar 31, 2026
- Accession Number
- 0001493152-26-014503
- Form Type
- 4
- Net Trading Amount
- $30.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 31, 2026 | Ordinary Shares | 15,000 | $2.04 | Purchase | $30.6K |
Want live alerts when Teleman Dan Benjamin trades again?
Download Insider Trades to track NSRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.